Article

Vaccination Induces Stronger Spike Immunity and Better Protection Against SARS-CoV-2 Infection in COVID-19 Recovered Subjects than in Naïve Individuals

2022-01-13

Abstract excerpt

Background; As the Covid-19 pandemic remains uncontrolled despite the introduction of multiple vaccines, it is essential to identify populations with the highest risk of being infected or re-infected.<br><br>Methods: To address this question, Spike-specific humoral and cellular immunity were compared in several groups of subjects from different cohorts, 6 months post-infection or post-vaccination in naïve or previ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 420116fc-f44c-5bb6-82fa-82af2607254e
DOI: 10.2139/ssrn.4000583

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Vaccination Induces Stronger Spike Immunity and Better Protection Against SARS-CoV-2 Infection in COVID-19 Recovered Subjects than in Naïve IndividualsDOI 10.2139/ssrn.4000583Read

Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalizationSemantic proximity Read

Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS‐CoV‐2 vaccinationSemantic proximity Read

Vaccination boosts protective responses and counters SARS-CoV-2-induced pathogenic memory B cellsSemantic proximity Read

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19Semantic proximity Read

Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patientsSemantic proximity Read

Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity.Semantic proximity Read

Clinical course impacts early kinetics and long-term magnitude and amplitude of SARS-CoV-2 neutralizing antibodies beyond one year after infectionSemantic proximity Read

COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infectionSemantic proximity Read

'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19Semantic proximity Read

Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and AgeSemantic proximity Read

Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD studySemantic proximity Read

Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 StudySemantic proximity Read